ENFLONSIA is Merck’s extended half-life monoclonal antibody (mAb) indicated for passive immunization for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in ...

About RSV Respiratory syncytial virus (RSV) is a contagious virus that causes widespread seasonal infections and can lead to serious respiratory conditions such as bronchiolitis and pneumonia.

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Respiratory infections such as COVID-19 have been responsible for numerous pandemics and have placed a substantial burden on ...

A 4·6 billion-year-old patient of ill-defined sex is seen in the emergency room because of multiple, uncontrolled respiratory ...

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

Understand the differences in symptoms, diagnosis, and treatment for these three common respiratory illnesses.

The virus exhibits a complex neuroinvasive profile and its pathogenesis is mediated through persistent infection in the central nervous system, often resulting in diffuse inflammatory lesions.